Your browser doesn't support javascript.
loading
Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational study.
Atreya, Mihir R; Cvijanovich, Natalie Z; Fitzgerald, Julie C; Weiss, Scott L; Bigham, Michael T; Jain, Parag N; Schwarz, Adam J; Lutfi, Riad; Nowak, Jeffrey; Allen, Geoffrey L; Thomas, Neal J; Grunwell, Jocelyn R; Baines, Torrey; Quasney, Michael; Haileselassie, Bereketeab; Lindsell, Christopher J; Alder, Matthew N; Wong, Hector R.
  • Atreya MR; Division of Critical Care Medicine, MLC2005, Cincinnati Children's Hospital Medical Center, Cincinnati Children's Research Foundation, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. Mihir.Atreya@cchmc.org.
  • Cvijanovich NZ; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA. Mihir.Atreya@cchmc.org.
  • Fitzgerald JC; UCSF Benioff Children's Hospital Oakland, Oakland, CA, 94609, USA.
  • Weiss SL; Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
  • Bigham MT; Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
  • Jain PN; Akron Children's Hospital, Akron, OH, 44308, USA.
  • Schwarz AJ; Texas Children's Hospital and Baylor College of Medicine, Houston, TX, 77030, USA.
  • Lutfi R; Children's Hospital of Orange County, Orange, CA, 92868, USA.
  • Nowak J; Riley Hospital for Children, Indianapolis, IN, 46202, USA.
  • Allen GL; Children's Hospital and Clinics of Minnesota, Minneapolis, MN, 55404, USA.
  • Thomas NJ; Children's Mercy Hospital, Kansas City, MO, 64108, USA.
  • Grunwell JR; Penn State Hershey Children's Hospital, Hershey, PA, 17033, USA.
  • Baines T; Children's Healthcare of Atlanta at Egleston, Atlanta, GA, 30322, USA.
  • Quasney M; University of Florida Health Shands Children's Hospital, Gainesville, FL, 32610, USA.
  • Haileselassie B; CS Mott Children's Hospital at the University of Michigan, Ann Arbor, MI, 48109, USA.
  • Lindsell CJ; Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.
  • Alder MN; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 37212, USA.
  • Wong HR; Division of Critical Care Medicine, MLC2005, Cincinnati Children's Hospital Medical Center, Cincinnati Children's Research Foundation, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
Crit Care ; 26(1): 210, 2022 07 11.
Article en En | MEDLINE | ID: mdl-35818064
BACKGROUND: Multiple organ dysfunction syndrome (MODS) is a critical driver of sepsis morbidity and mortality in children. Early identification of those at risk of death and persistent organ dysfunctions is necessary to enrich patients for future trials of sepsis therapeutics. Here, we sought to integrate endothelial and PERSEVERE biomarkers to estimate the composite risk of death or organ dysfunctions on day 7 of septic shock. METHODS: We measured endothelial dysfunction markers from day 1 serum among those with existing PERSEVERE data. TreeNet® classification model was derived incorporating 22 clinical and biological variables to estimate risk. Based on relative variable importance, a simplified 6-biomarker model was developed thereafter. RESULTS: Among 502 patients, 49 patients died before day 7 and 124 patients had persistence of MODS on day 7 of septic shock. Area under the receiver operator characteristic curve (AUROC) for the newly derived PERSEVEREnce model to predict death or day 7 MODS was 0.93 (0.91-0.95) with a summary AUROC of 0.80 (0.76-0.84) upon tenfold cross-validation. The simplified model, based on IL-8, HSP70, ICAM-1, Angpt2/Tie2, Angpt2/Angpt1, and Thrombomodulin, performed similarly. Interaction between variables-ICAM-1 with IL-8 and Thrombomodulin with Angpt2/Angpt1-contributed to the models' predictive capabilities. Model performance varied when estimating risk of individual organ dysfunctions with AUROCS ranging from 0.91 to 0.97 and 0.68 to 0.89 in training and test sets, respectively. CONCLUSIONS: The newly derived PERSEVEREnce biomarker model reliably estimates risk of death or persistent organ dysfunctions on day 7 of septic shock. If validated, this tool can be used for prognostic enrichment in future pediatric trials of sepsis therapeutics.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Choque Séptico / Sepsis Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Choque Séptico / Sepsis Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Año: 2022 Tipo del documento: Article